These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10501204)

  • 1. Toxicity of pyroglutaminated amyloid beta-peptides 3(pE)-40 and -42 is similar to that of A beta1-40 and -42.
    Tekirian TL; Yang AY; Glabe C; Geddes JW
    J Neurochem; 1999 Oct; 73(4):1584-9. PubMed ID: 10501204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyroglutamate-modified amyloid beta-peptides--AbetaN3(pE)--strongly affect cultured neuron and astrocyte survival.
    Russo C; Violani E; Salis S; Venezia V; Dolcini V; Damonte G; Benatti U; D'Arrigo C; Patrone E; Carlo P; Schettini G
    J Neurochem; 2002 Sep; 82(6):1480-9. PubMed ID: 12354296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation among secondary structure, amyloid precursor protein accumulation, and neurotoxicity of amyloid beta(25-35) peptide as analyzed by single alanine substitution.
    Sato K; Wakamiya A; Maeda T; Noguchi K; Takashima A; Imahori K
    J Biochem; 1995 Dec; 118(6):1108-11. PubMed ID: 8720122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino-terminal deletions enhance aggregation of beta-amyloid peptides in vitro.
    Pike CJ; Overman MJ; Cotman CW
    J Biol Chem; 1995 Oct; 270(41):23895-8. PubMed ID: 7592576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ApoE protects cortical neurones against neurotoxicity induced by the non-fibrillar C-terminal domain of the amyloid-beta peptide.
    Drouet B; Fifre A; Pinçon-Raymond M; Vandekerckhove J; Rosseneu M; Guéant JL; Chambaz J; Pillot T
    J Neurochem; 2001 Jan; 76(1):117-27. PubMed ID: 11145984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nonfibrillar amyloid beta-peptide induces apoptotic neuronal cell death: involvement of its C-terminal fusogenic domain.
    Pillot T; Drouet B; Queillé S; Labeur C; Vandekerchkhove J; Rosseneu M; Pinçon-Raymond M; Chambaz J
    J Neurochem; 1999 Oct; 73(4):1626-34. PubMed ID: 10501209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amidation of beta-amyloid peptide strongly reduced the amyloidogenic activity without alteration of the neurotoxicity.
    Forloni G; Lucca E; Angeretti N; Della Torre P; Salmona M
    J Neurochem; 1997 Nov; 69(5):2048-54. PubMed ID: 9349550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboxyl-terminal fragment of Alzheimer's APP destabilizes calcium homeostasis and renders neuronal cells vulnerable to excitotoxicity.
    Kim HS; Park CH; Cha SH; Lee JH; Lee S; Kim Y; Rah JC; Jeong SJ; Suh YH
    FASEB J; 2000 Aug; 14(11):1508-17. PubMed ID: 10928985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of alpha 1-antichymotrypsin on the toxicity of beta-amyloid fragment 25-40 in rat primary cultured neurons.
    Kobayashi T; Abe K; Saito H; Nishiyama N
    Neurosci Lett; 1994 May; 172(1-2):147-50. PubMed ID: 8084521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity of prion protein peptide (PrP106-126) differs in mechanism from the cytotoxic activity of the Alzheimer's disease amyloid peptide, A beta 25-35.
    Hope J; Shearman MS; Baxter HC; Chong A; Kelly SM; Price NC
    Neurodegeneration; 1996 Mar; 5(1):1-11. PubMed ID: 8731376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures.
    Pike CJ; Walencewicz AJ; Glabe CG; Cotman CW
    Eur J Pharmacol; 1991 Aug; 207(4):367-8. PubMed ID: 1783006
    [No Abstract]   [Full Text] [Related]  

  • 12. Spontaneous aggregation and cytotoxicity of the beta-amyloid Abeta1-40: a kinetic model.
    Taylor BM; Sarver RW; Fici G; Poorman RA; Lutzke BS; Molinari A; Kawabe T; Kappenman K; Buhl AE; Epps DE
    J Protein Chem; 2003 Jan; 22(1):31-40. PubMed ID: 12739896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloidogenicity and toxicity of the reverse and scrambled variants of amyloid-β 1-42.
    Vadukul DM; Gbajumo O; Marshall KE; Serpell LC
    FEBS Lett; 2017 Mar; 591(5):822-830. PubMed ID: 28185264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotoxicity and oxidative stress in D1M-substituted Alzheimer's A beta(1-42): relevance to N-terminal methionine chemistry in small model peptides.
    Boyd-Kimball D; Sultana R; Mohmmad-Abdul H; Butterfield DA
    Peptides; 2005 Apr; 26(4):665-73. PubMed ID: 15752582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of the carboxyl terminus of the Alzheimer Abeta peptide on its conformation, aggregation, and neurotoxic properties.
    Soreghan B; Pike C; Kayed R; Tian W; Milton S; Cotman C; Glabe CG
    Neuromolecular Med; 2002; 1(1):81-94. PubMed ID: 12025818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laminin affects polymerization, depolymerization and neurotoxicity of Abeta peptide.
    Morgan C; Bugueño MP; Garrido J; Inestrosa NC
    Peptides; 2002 Jul; 23(7):1229-40. PubMed ID: 12128080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of N-terminal Mutations on β-amyloid Peptide Aggregation and Toxicity.
    Foroutanpay BV; Kumar J; Kang SG; Danaei N; Westaway D; Sim VL; Kar S
    Neuroscience; 2018 May; 379():177-188. PubMed ID: 29572166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factors-beta protect primary rat hippocampal neuronal cultures from degeneration induced by beta-amyloid peptide.
    Ren RF; Flanders KC
    Brain Res; 1996 Sep; 732(1-2):16-24. PubMed ID: 8891264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Leu(34)-Met(35) in neurotoxicity caused by human beta-amyloid (1-42) peptide in vitro.
    Pákáski M; Farkas Z; Soós K; Penke B; Kása P
    Neurobiology (Bp); 1996; 4(3):273-4. PubMed ID: 9044363
    [No Abstract]   [Full Text] [Related]  

  • 20. Temporal relations among amyloid beta-peptide-induced free-radical oxidative stress, neuronal toxicity, and neuronal defensive responses.
    Yatin SM; Aksenova M; Aksenov M; Markesbery WR; Aulick T; Butterfield DA
    J Mol Neurosci; 1998 Dec; 11(3):183-97. PubMed ID: 10344789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.